Elpis eyes strategic partnerships as it works to scale ‘direct cell reprogramming’ tech 14-Dec-2018 By Melissa Fassbender Elpis Biomed is scaling its proprietary ‘direct cellular reprogramming platform’ – and has its sights set on becoming a global provider of high-quality human cells, with strategic partnerships soon to be announced, says the company’s founder.